Mycenax Biotech Inc., established in Sep. 2001, is a biopharmaceutical product development and manufacturing organization specializing in mammalian and microbial cell derived biologics. Mycenax utilizes most advanced Single-use technology” throughout the production process from cell cultivation, scale production, harvest, purification and fill/finishing including lyophilization. Current scale is 3,200 L per lot perfusion, 500 gm per down-stream, and up to 8,000 liquid fill per day. Mycenax operates from state-of-the-art facilities located at the Jhunan Science Base Park, Taiwan. Our 1,650 sq. meters (18,000 sq. ft) module designed, multi-product cGMP facility features upstream suites including Wave bioreactor (200 L perfusion); downstream suites, and fill/finishing/lyophilization suites as well as associated supported laboratories.
Headquarters
7F., No. 66, Shengyi 2Nd Rd Zhubei City
Hsinchu City; Hsinchu City;
Contact Details: Purchase the Mycenax Biotech Inc. (永昕生物医药股份有限公司) report to view the information.
Website: http://www.mycenax.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service